E-mail
Contact Us
home Customized Product Tesamorelin

Tesamorelin

CAS No.: 218949-48-5
Tesamorelin Chemical Structure

Molecular formula:C221H366N72O67S

Molecular weight: 5134.7233

Patent period: —

Dositive specifications:2 mg BASE/VIAL

Injection :2 mg /once day

Oral tablets: —

Injection: —

Products are for laboratory research use only. Not for human use. We do not sell to patients.
Biological Activity

EGRIFTA is a growth hormone releasing factor (GRF) analogindicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy:

__ EGRIFTA

Chemical Properties
ACTIONS
CAS NO. 218949-48-5
FORMULA C221H366N72O67S
M. WT 5134.7233
PURITY
SYNONYMS TesamorelinAcetate Tesamorelin(usan)USP/EP/BP
D06655 Tesamorelin (usan)
STORAGE
Online Inquiry
Product Online Inquiry
Other Drug Peptide More+